StarZero All shows Try the podcast clipper →

pharmaceutical industry

3 statements across 1 episodes · 0 bullish · 0 bearish · 1 people on the record · first statement Jan 22, 2024 by Ben Gilbert · across every show →

Everything said about pharmaceutical industry, oldest first

Jan 22, 2024
Assertion Supported
Most approved pharmaceutical drugs fail to recoup their R&D costs
“Most drugs, this is also a crazy stat, even after they are approved, do not earn back their R&D costs.”
Ben Gilbert Jan 22, 2024 ▶ 3:13:03 Novo Nordisk (Ozempic) · Acquired
Jan 22, 2024
Assertion Supported
Average drug development costs rose from $40 million to $2.5 billion
“If you just look at the cost to bring a drug to market in 1953, It costs forty million dollars for an approval, and that's an inflation-adjusted figure. Today, it averages 2.5 billion.”
Ben Gilbert Jan 22, 2024 ▶ 3:10:59 Novo Nordisk (Ozempic) · Acquired
Jan 22, 2024
Assertion Supported
Only 10% of clinical drugs reach market, with one driving profits
“If you look at the pipeline of a hundred drugs that enter clinical development, 10 actually make it to market, and one provides, get this, half the profits.”
Ben Gilbert Jan 22, 2024 ▶ 3:12:38 Novo Nordisk (Ozempic) · Acquired
Made with StarZero

Turn any episode into a week of clips.

This entire site, nearly 80 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more